Published in Brain Res on May 03, 1991
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev (2007) 1.62
Abnormalities in skilled reaching movements are improved by peripheral anesthetization of the less-affected forelimb after sensorimotor cortical infarcts in rats. Behav Brain Res (2006) 0.93
The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. Nat Commun (2012) 0.92
Characterization of the temporo-spatial effects of chronic bilateral intrahippocampal cannulae on interleukin-1beta. J Neurosci Methods (2007) 0.90
Metabolic and pathological effects of temporal lobe epilepsy in rat brain detected by proton spectroscopy and imaging. Brain Res (1997) 0.81
Histocompatibility and in vivo signal throughput for PEDOT, PEDOP, P3MT, and polycarbazole electrodes. J Biomed Mater Res A (2012) 0.80
The role of different strain backgrounds in bacterial endotoxin-mediated sensitization to neonatal hypoxic-ischemic brain damage. Neuroscience (2015) 0.79
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem (1993) 3.21
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol (1996) 1.84
Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem (2004) 1.83
Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci (1999) 1.81
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res (2001) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol (1991) 1.54
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci (1994) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci (2001) 1.38
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett (2000) 1.36
Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol (1985) 1.26
MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol (1998) 1.26
Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ (2005) 1.25
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med (1984) 1.23
Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res (2000) 1.21
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem (1999) 1.20
Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J Neuropathol Exp Neurol (2001) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler (2007) 1.18
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol (2000) 1.17
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett (1986) 1.17
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain (1999) 1.17
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Overexpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci (1996) 1.17
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia (2007) 1.16
Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol (2001) 1.15
Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J Clin Invest (1997) 1.15
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol (2000) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol (1981) 1.12
Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene (2001) 1.12
Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res (1996) 1.11
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Inhibition of medulloblastoma cell invasion by Slit. Oncogene (2006) 1.09
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol (1995) 1.04
A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol (1995) 1.04
HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol (2001) 1.04
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia (1998) 1.03
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Clin Cancer Res (1999) 1.03
Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest (1996) 1.02
IL-10 production by adult human derived microglial cells. Neurochem Int (1996) 1.02
Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism. Glia (2001) 1.01
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult Scler (2009) 1.01
Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol (1987) 1.01
Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol (1996) 1.00
Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00
Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis (1996) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Attenuation of astroglial reactivity by interleukin-10. J Neurosci (1996) 0.98
CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol (2000) 0.98
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci (1995) 0.98
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery (1991) 0.97
Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol (1999) 0.96
Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol (2000) 0.96
Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J Virol (1997) 0.95
Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology (2000) 0.95
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J Neuroimmunol (1997) 0.95
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol (1982) 0.94
Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci (1997) 0.94
Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol (2000) 0.93
Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann Neurol (1999) 0.93
p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci (1998) 0.93
T cell regulation of polyclonally induced immunoglobulin secretion in humans. J Immunol (1984) 0.93
Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J Immunol (1999) 0.92
NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol (2001) 0.92
Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol (1987) 0.92
Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci (1997) 0.92
Immunohistochemical studies of adult human glial cells. J Neuroimmunol (1989) 0.92